Dr. Reddy's Laboratories (RDY) Hmangaihna Thlan
Rdy
Thlanh chiah a ngai$12.26Updated 25 Sep 2026 19:59 UTC
Change-0.24%
AI forecast: RDY
The AI publishes a target price for the next trading day, the end of the week and the end of the month. The change is measured from the latest price. These are statistical estimates, not investment advice.
Lai a ngaih a hnu a 6 thlang
Premium shows the AI's price targets for 1 day, 1 week and 1 month for this and every other stock.
Unlock Premium🔒 Ri hlaam thlan a nih hi
The forecast track record — every past forecast next to the actual close — is part of Premium.
Unlock PremiumHmi hnuai thawn
Dr. Reddy’s Laboratories Ltd. provides a full range of pharmaceutical services. The company manufactures bulk drugs and formulations, including verapamil and cephalexin. It also produces and exports molecules such as norfloxacin, ciprofloxacin, and varieties of semi-synthetic penicillin. The company sells its products in India and worldwide.
